{"Name":"Neurotrack","perma":"neurotrack-technologies","BasicInfo":{"funded":"2012-01-01","isClosed":false,"closed":null,"short":"Neurotrack's technology can predict the onset of Alzheimer's disease three to six years before symptoms occur."},"FundingRounds":[{"funding_type":"grant","series":null,"announcedDate":"2016-12-01","moneyRaised":1000000},{"funding_type":"venture","series":"A","announcedDate":"2016-01-27","moneyRaised":6500000},{"funding_type":"debt_financing","series":null,"announcedDate":"2014-12-29","moneyRaised":1000000},{"funding_type":"seed","series":null,"announcedDate":"2013-09-26","moneyRaised":2000000},{"funding_type":"seed","series":null,"announcedDate":"2013-05-22","moneyRaised":90000}],"Acquisitions":[],"AcquiredBy":null,"IPO":null,"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"Chief Operating Officer","started":null,"ended":null,"firstName":"Caitlyn","lastName":"Waller Krebs"},{"title":"Co-founder/ CEO","started":null,"ended":null,"firstName":"Elli","lastName":"Kaplan"}],"PastTeam":[]}
